The IPD-IMGT/HLA database: recent developments in sequence submission
Nucleic Acids Research · 06.01.2026 · 54 (D1) · D1152-D1158
DOI: 10.1093/nar/gkaf1218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.11.2025. Verfasst von Dominic J Barker und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anthony Nolan Research Institute, London, NW3 2QG, United Kingdom. Hauptthemen laut MEDLINE: HLA Antigens, Databases, Genetic, Databases, Nucleic Acid. Die Arbeit wurde bisher 189-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NMDP, CareDX, DKMS.
Abstract (Originalsprache)
The IPD-IMGT/HLA Database, https://www.ebi.ac.uk/ipd/imgt/hla/, contains >43 000 unique alleles from 47 genes recognized by the WHO Nomenclature Committee for Factors of the HLA System. The HLA system, located within the human major histocompatibility complex on chromosome 6, represents the most polymorphic genes in the human genome and is described as hyperpolymorphic. With the rapid growth of HLA sequencing worldwide, traditional approaches for submitting and accessing data have been challenged. To address these challenges, the IPD-IMGT/HLA Database has expanded its infrastructure by developing Application Programming Interfaces, enabling flexible queries via both a web-based interface and programmatic access. A major advancement is the launch of a new HLA Submission Tool, replacing the previous system after 26 years and >28 000 submissions. The updated tool provides a streamlined user experience, extensive data validation, and automated submissions through an application program interface (API). Importantly, it eliminates the burden of duplicate submissions by offering optional brokering to the European Nucleotide Archive on our submitters’ behalf, representing sequences in both databases while ensuring attribution. Together, the new submission tool, submission API, and ENA brokering reduce workload, increase efficiency, and provide ongoing support for the global HLA community.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Anthony Nolan Research Institute, London, NW3 2QG, United Kingdom.
- UCL Cancer Institute, University College London (UCL), London, WC1E 6DD, United Kingdom.
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton,Cambridge, CB10 1SD, United Kingdom.
- Departments of Structural Biology and, Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, United States.
ORCID-Profile: Dominic J Barker, Richard H L Natarajan, Sebastian J F Hopper, Andrew D Yates, Steven G E Marsh, James Robinson
Förderung
- NMDP
- CareDX
- DKMS
- Scisco Genetics
- European Federation for Immunogenetics
- Thermo Fisher Scientific
- Werfen
- LabCorp
Zitieren
APA
Barker, D. J., Natarajan, R. H. L., Cooper, M. A., Hopper, S. J. F., Yates, A. D., Parham, P., Marsh, S. G. E., & Robinson, J. (2026). The IPD-IMGT/HLA database: recent developments in sequence submission. Nucleic Acids Research, 54(D1), D1152-D1158. https://doi.org/10.1093/nar/gkaf1218
Vancouver
Barker DJ, Natarajan RHL, Cooper MA, Hopper SJF, Yates AD, Parham P, et al. The IPD-IMGT/HLA database: recent developments in sequence submission. Nucleic Acids Research. 2026;54(D1):D1152-D1158. doi:10.1093/nar/gkaf1218
BibTeX
@article{Barker2026,
author = {Barker, Dominic J and Natarajan, Richard H L and Cooper, Michael A and Hopper, Sebastian J F and Yates, Andrew D and Parham, Peter and Marsh, Steven G E and Robinson, James},
title = {The IPD-IMGT/HLA database: recent developments in sequence submission},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {D1},
pages = {D1152--D1158},
doi = {10.1093/nar/gkaf1218}
}
EUVIMED